Literature DB >> 24646421

Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes 2.

Chin-Hsiao Tseng1.   

Abstract

Entities:  

Keywords:  Taiwan; diabetes; epidemiology; pioglitazone; thyroid cancer

Mesh：

Substances：

Year:  2014        PMID： 24646421     DOI： 10.1111/1753-0407.12149

Source DB:  PubMed          Journal:  J Diabetes        ISSN： 1753-0407            Impact factor:   4.006


× No keyword cloud information.
  5 in total

1.  Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis.

Authors:  Chin-Hsiao Tseng
Journal:  BMC Cancer       Date:  2022-05-18       Impact factor: 4.638

Review 2.  Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?

Authors:  Roberta Malaguarnera; Veronica Vella; Maria Luisa Nicolosi; Antonino Belfiore
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-14       Impact factor: 5.555

3.  The Association between Type 2 Diabetes Mellitus and Thyroid Cancer.

Authors:  Young-Gyun Seo; Ho-Chun Choi; Ah Reum An; Do Joon Park; Young Joo Park; Kyu Eun Lee; Sue K Park; Yunji Hwang; Belong Cho
Journal:  J Diabetes Res       Date:  2017-07-09       Impact factor: 4.011

Review 4.  Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer.

Authors:  Melody Chiu; Lucien McBeth; Puneet Sindhwani; Terry D Hinds
Journal:  PPAR Res       Date:  2017-02-28       Impact factor: 4.964

5.  Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes.

Authors:  Hua Qu; Yi Zheng; Yuren Wang; Rui Zhang; Xiongzhong Ruan; Gangyi Yang; Zhenqi Liu; Hongting Zheng
Journal:  Sci Rep       Date:  2017-11-17       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.